Norges Bank Amneal Pharmaceuticals, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $462,032 - $612,882	86,200 New	86,200 $547,000
Q1 2023 May 15, 2024	BUY	$1.27 - $2.7 $90,297 - $191,970	71,100 New	71,100 $98,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $5.32 Million - $7.08 Million	2,714,400 New	2,714,400 $5.4 Million
Q1 2022 May 12, 2023	SELL	$3.9 - $4.89 $8.87 Million - $11.1 Million	-2,275,143 Reduced 83.82%	439,257 $1.83 Million
Q1 2022 May 09, 2022	SELL	$3.9 - $4.89 $2.65 Million - $3.33 Million	-680,709 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$3.95 - $5.85 $2.69 Million - $3.98 Million	680,709 New	680,709 $3.26 Million
Q3 2021 Nov 14, 2022	BUY	$4.31 - $5.64 $3.28 Million - $4.29 Million	761,253 New	761,253 $4.07 Million
Q3 2021 Nov 05, 2021	SELL	$4.31 - $5.64 $3.28 Million - $4.29 Million	-761,253 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$5.12 - $6.82 $3.9 Million - $5.19 Million	761,253 New	761,253 $3.9 Million
Q2 2021 Aug 10, 2021	SELL	$5.12 - $6.82 $4.14 Million - $5.51 Million	-807,906 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$4.74 - $7.38 $3.83 Million - $5.96 Million	807,906 New	807,906 $5.44 Million
Q1 2021 May 07, 2021	SELL	$4.74 - $7.38 $5.19 Million - $8.07 Million	-1,093,954 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$3.95 - $5.42 $4.32 Million - $5.93 Million	1,093,954 New	1,093,954 $5 Million
Q4 2020 Feb 10, 2021	SELL	$3.95 - $5.42 $4.32 Million - $5.93 Million	-1,093,954 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$3.54 - $5.27 $3.87 Million - $5.77 Million	1,093,954 New	1,093,954 $4.25 Million
Q3 2020 Nov 10, 2020	SELL	$3.54 - $5.27 $3.78 Million - $5.63 Million	-1,068,255 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$2.87 - $5.46 $3.07 Million - $5.83 Million	1,068,255 New	1,068,255 $5.09 Million
Q2 2020 Aug 07, 2020	SELL	$2.87 - $5.46 $3.24 Million - $6.16 Million	-1,127,504 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$2.46 - $5.35 $2.77 Million - $6.03 Million	1,127,504 New	1,127,504 $3.92 Million
Q1 2020 May 08, 2020	SELL	$2.46 - $5.35 $2.62 Million - $5.7 Million	-1,064,611 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$2.65 - $5.56 $2.82 Million - $5.92 Million	1,064,611 New	1,064,611 $5.13 Million
Q4 2019 Feb 12, 2020	SELL	$2.65 - $5.56 $3.81 Million - $7.98 Million	-1,436,092 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$2.29 - $7.1 $3.29 Million - $10.2 Million	1,436,092 New	1,436,092 $4.17 Million
Q3 2019 Nov 08, 2019	SELL	$2.29 - $7.1 $3.09 Million - $9.57 Million	-1,348,373 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$6.44 - $14.29 $8.68 Million - $19.3 Million	1,348,373 New	1,348,373 $9.67 Million
Q2 2019 Aug 09, 2019	SELL	$6.44 - $14.29 $8.68 Million - $19.3 Million	-1,348,373 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$13.09 - $21.49 $17.7 Million - $29 Million	1,348,373 New	1,348,373 $18.2 Million
Q4 2018 Feb 08, 2019	SELL	$13.09 - $21.49 $16.2 Million - $26.6 Million	-1,238,856 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$16.4 - $24.27 $20.3 Million - $30.1 Million	1,238,856 New	1,238,856 $27.5 Million
Q3 2018 Nov 09, 2018	SELL	$16.4 - $24.27 $18.4 Million - $27.3 Million	-1,123,030 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$13.95 - $20.2 $15.7 Million - $22.7 Million	1,123,030 New	1,123,030 $18.4 Million

Others Institutions Holding AMRX

# of Institutions

184

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account